top of page
PVLMC-logo-mockup-4(1).jpg

 Consulting Services

Subject Matter Expert (SME) Consulting Services

We have experience with:
  • All Biologics Manufacturing Process Development and Commercialization (Therapeutic Proteins, Vaccines, Immunotherapies, etc.)
     

  • Upstream and Downstream Processing with All Cell Line Hosts (Bacterial, Yeast, Mammalian, etc.)
     

  • Authoring of all Regulatory Filings for Biologics                           

  • Regulatory Compliance Assessments                                           

  • Clinical Data and Regulatory Submission Management

Meeting Icon.jpg

1

​Process Validation Stage 1 

  • Process Validation Master Plan Authoring and Review,

  • Critical Quality Attribute (CQA) Determination,

  • Key Process Attribute (KPA) Determination,

  • ​Critical Process Parameter (CPP) Determination,

  • Key Operating Parameter (KOP) Determination,

  • Process Development and Characterization,

  • Master Cell Bank (MCB)/Working Cell Bank (WCB) Characterization and Stability Qualification,

  • Failure Modes and Effect Analysis (FMEA),

  • Leachable/Extractable Risk Evaluation,

  • Raw Material Risk Evaluation,

  • Process Control Strategy Authoring and Review.

2

Process Validation Stage 2​

  • Process Performance Qualification (PPQ) Readiness Planning and Deployment (Right First-time),

  • Process Validation Study Design and Templating,

  • Process Performance Qualification (PPQ) Protocol and Report Authoring and Review (Upstream and Downstream Processes),

  • Design and Authoring of Misc. Qualifications:

    • Fermentation/Cell Culture Media Hold Qual.,

    • Solution/Buffer Hold Qual.,

    • Equipment or Product Pool Mixing Studies,

    • Product Re-filtration Qual.,

    • Intermediate (In-Process Pool) Hold Qual.,

    • Leachables/Extractables Assessment, 

    • Drug substance filter validation,

    • Drug Substance Homogeneity Qual.,

    • Container Closure Integrity Testing,

    • Chromatography Resin Re-use Qual.,

    • TFF or UF/DF Membrane Re-use Qual.,

    • Transport Validation (MCB/WCB, Analytical Samples, BDS, DP)

  • Product Comparability Assessments,

  • Pre-approval Inspection (PAI) Preparation and Compliance Review,

  • Authoring and Review of Drug Substance BLA/NDA (3.2.S.2), MAA, IND, IMPD, and APR Sections,

  • Due Diligence Review: Contract Manufacturing Organizations (CMO), Partnership Organizations and Acquisitions,

  • Regulatory Compliance Assessments,

  • Auditing.

3

Process Validation Stage 3

  • Continued Process Verification (CPV),

  • Non-conformance Investigation,

  • Corrective-action/Preventative-action (CAPA) Implementation,

  • Validation Maintenance,

  • Annual Product Review Assessment (APR).

091794312-antibody.jpeg

Quality System Design Services

  • Critical Quality Attribute (CQA) Determination Policies,
     

  • Global Process Validation System Review, Development, and Harmonization,
     

  • Process Validation Stages (1, 2, and 3) Policies,
     

  • Process Validation Core Requirements,
     

  • Application of FDA/ICH Regulatory Standards and Industry Best Practices for Process Validation,
     

  • Validation Maintenance Policies.

On-site Consulting Training

  • Introduction to Process Validation: Basic Strategies and Requirements,

  • Chromatography Resin and UF/DF Membrane Re-use Validation,

  • Intermediate Pool Hold Validation,

  • Risk Assessment of Filter and Component Leachables/Extractables,

  • Media, Buffer, and Solution Hold Validation,

  • Risk Assessment of Microbial/Endotoxin Ingress,

  • Process Performance Qualification Readiness,

  • Determination of Critical Quality Attributes by Risk Assessment,

  • Determination of High-risk Raw Materials by Risk Assessment,

  • Introduction to Process Characterization: Concepts and Strategies, 

  • Re-filtration Validation,

  • Transport Validation.

shutterstock_2262931501 cropped.jpg

On-site Consulting Training

  • Introduction to Process Validation: Basic Strategies and Requirements,

  • Chromatography Resin and UF/DF Membrane Re-use Validation,

  • Intermediate Pool Hold Validation,

  • Risk Assessment of Filter and Component Leachables/Extractables,

  • Media, Buffer, and Solution Hold Validation,

  • Risk Assessment of Microbial/Endotoxin Ingress,

  • Process Performance Qualification Readiness,

  • Determination of Critical Quality Attributes by Risk Assessment,

  • Determination of High-risk Raw Materials by Risk Assessment,

  • Introduction to Process Characterization: Concepts and Strategies, 

  • Re-filtration Validation,

  • Transport Validation.

shutterstock_2238369719.jpg
bottom of page